I
294.53
-0.66 (-0.22%)
| Penutupan Terdahulu | 295.19 |
| Buka | 296.45 |
| Jumlah Dagangan | 275,544 |
| Purata Dagangan (3B) | 658,692 |
| Modal Pasaran | 20,732,536,832 |
| Harga / Pendapatan (P/E TTM) | 86.12 |
| Harga / Pendapatan (P/E Ke hadapan) | 42.02 |
| Harga / Jualan (P/S) | 7.40 |
| Harga / Buku (P/B) | 13.04 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 6 Nov 2025 |
| Margin Keuntungan | 18.29% |
| Margin Operasi (TTM) | 15.61% |
| EPS Cair (TTM) | 5.54 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 28.80% |
| Pertumbuhan Pendapatan Suku Tahunan (YOY) | -31.30% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 131.40% |
| Nisbah Semasa (MRQ) | 4.47 |
| Aliran Tunai Operasi (OCF TTM) | 406.50 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 84.25 M |
| Pulangan Atas Aset (ROA TTM) | 6.94% |
| Pulangan Atas Ekuiti (ROE TTM) | 37.92% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Devices (US) | Bercampur | Bercampur |
| Medical Devices (Global) | Bercampur | Bercampur | |
| Stok | Insulet Corporation | Menurun | Menaik |
AISkor Stockmoo
0.0
| Konsensus Penganalisis | 1.5 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 1.0 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | -2.5 |
| Purata | 0.00 |
|
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide. |
|
| Sektor | Healthcare |
| Industri | Medical Devices |
| Gaya Pelaburan | Mid Growth |
| % Dimiliki oleh Orang Dalam | 0.29% |
| % Dimiliki oleh Institusi | 102.56% |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 450.00 (Canaccord Genuity, 52.79%) | Beli |
| Median | 380.00 (29.02%) | |
| Rendah | 274.00 (Barclays, -6.97%) | Jual |
| Purata | 375.82 (27.60%) | |
| Jumlah | 10 Beli, 1 Jual | |
| Harga Purata @ Panggilan | 303.81 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Stifel | 04 Feb 2026 | 350.00 (18.83%) | Beli | 251.22 |
| Barclays | 12 Jan 2026 | 274.00 (-6.97%) | Jual | 278.55 |
| 07 Nov 2025 | 316.00 (7.29%) | Pegang | 319.82 | |
| Bernstein | 09 Jan 2026 | 380.00 (29.02%) | Beli | 289.04 |
| Truist Securities | 18 Dec 2025 | 390.00 (32.42%) | Beli | 292.88 |
| 21 Nov 2025 | 412.00 (39.89%) | Beli | 331.17 | |
| Canaccord Genuity | 17 Dec 2025 | 450.00 (52.79%) | Beli | 289.57 |
| 24 Nov 2025 | 432.00 (46.68%) | Beli | 337.53 | |
| Evercore ISI Group | 16 Dec 2025 | 370.00 (25.62%) | Beli | 288.73 |
| BTIG | 21 Nov 2025 | 380.00 (29.02%) | Beli | 331.17 |
| 13 Nov 2025 | 370.00 (25.62%) | Beli | 332.67 | |
| RBC Capital | 21 Nov 2025 | 380.00 (29.02%) | Beli | 331.17 |
| 07 Nov 2025 | 370.00 (25.62%) | Beli | 319.82 | |
| UBS | 19 Nov 2025 | 400.00 (35.81%) | Beli | 346.36 |
| 07 Nov 2025 | 355.00 (20.53%) | Pegang | 319.82 | |
| Wells Fargo | 07 Nov 2025 | 360.00 (22.23%) | Beli | 319.82 |
| Jefferies | 06 Nov 2025 | 400.00 (35.81%) | Beli | 323.40 |
| Papar semua | ||||
Tiada data dalam julat masa ini.
| Tarikh | Jenis | Butiran |
|---|---|---|
| 09 Jan 2026 | Pengumuman | Insulet to Announce Fourth Quarter and Full Year 2025 Financial Results on February 18, 2026 |
| 06 Jan 2026 | Pengumuman | Insulet Redefines Diabetes at CES with "Liveable Technology" — A New Frontier in Human-Centered Connected Health |
| 16 Dec 2025 | Pengumuman | Insulet to Participate in 44th Annual J.P. Morgan Healthcare Conference |
| 15 Dec 2025 | Pengumuman | Insulet Expands Omnipod® U.S. Recycling Program, Diverting Millions of Pods from Landfills and Creating a More Sustainable Future |
| 04 Dec 2025 | Pengumuman | Insulet Announces FDA 510(k) Clearance of Omnipod® 5 Algorithm Enhancements that Redefine Insulin Delivery and Simplify the Pod Experience |
| 20 Nov 2025 | Pengumuman | Insulet Outlines Long-Term Strategy to Drive Growth and Value Creation at 2025 Investor Day |
| 06 Nov 2025 | Pengumuman | Insulet Reports Third Quarter 2025 Results |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |